Dentsply International Inc. (XRAY) Position Reduced by Headinvest LLC
Headinvest LLC cut its position in shares of Dentsply International Inc. (NASDAQ:XRAY) by 0.5% during the second quarter, Holdings Channel reports. The firm owned 98,921 shares of the company’s stock after selling 455 shares during the period. Dentsply International makes up 2.3% of Headinvest LLC’s holdings, making the stock its 10th largest position. Headinvest LLC’s holdings in Dentsply International were worth $6,137,000 as of its most recent SEC filing.
Several other hedge funds have also made changes to their positions in the stock. Norges Bank acquired a new stake in shares of Dentsply International during the fourth quarter worth $85,870,000. Chevy Chase Trust Holdings Inc. raised its stake in shares of Dentsply International by 74.2% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 212,862 shares of the company’s stock worth $13,118,000 after buying an additional 90,667 shares during the last quarter. Raymond James Trust N.A. raised its stake in shares of Dentsply International by 23.8% in the first quarter. Raymond James Trust N.A. now owns 5,511 shares of the company’s stock worth $339,000 after buying an additional 1,061 shares during the last quarter. First Manhattan Co. raised its stake in shares of Dentsply International by 581.9% in the first quarter. First Manhattan Co. now owns 9,778 shares of the company’s stock worth $602,000 after buying an additional 8,344 shares during the last quarter. Finally, Chesley Taft & Associates LLC purchased a new stake in shares of Dentsply International during the first quarter worth approximately $436,000. Institutional investors own 94.58% of the company’s stock.
Dentsply International Inc. (NASDAQ:XRAY) traded up 0.20% during trading on Thursday, hitting $60.01. The stock had a trading volume of 2,069,028 shares. The stock has a 50 day moving average of $60.68 and a 200 day moving average of $61.56. Dentsply International Inc. has a one year low of $49.48 and a one year high of $65.83. The firm has a market capitalization of $13.98 billion, a P/E ratio of 28.16 and a beta of 1.40.
Dentsply International (NASDAQ:XRAY) last posted its earnings results on Friday, August 5th. The company reported $0.76 EPS for the quarter, beating the consensus estimate of $0.70 by $0.06. The firm earned $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The business’s quarterly revenue was up 46.4% on a year-over-year basis. During the same period last year, the company earned $0.73 earnings per share. Equities research analysts expect that Dentsply International Inc. will post $2.76 earnings per share for the current fiscal year.
The company also recently announced a dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be given a $0.0775 dividend. The ex-dividend date is Wednesday, September 28th. Dentsply International’s dividend payout ratio is presently 14.49%.
A number of brokerages recently commented on XRAY. Piper Jaffray Cos. began coverage on Dentsply International in a research report on Monday, June 13th. They issued an “overweight” rating and a $70.00 price objective for the company. Credit Suisse Group AG reiterated a “buy” rating on shares of Dentsply International in a research report on Sunday, June 5th. Zacks Investment Research lowered Dentsply International from a “buy” rating to a “hold” rating in a research report on Monday, August 8th. Barrington Research lowered Dentsply International from an “outperform” rating to a “market perform” rating in a research report on Monday, August 8th. Finally, Jefferies Group reiterated a “buy” rating on shares of Dentsply International in a research report on Wednesday, August 17th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $67.00.
In other Dentsply International news, VP Rainer Berthan sold 5,000 shares of the stock in a transaction dated Tuesday, September 6th. The stock was sold at an average price of $61.12, for a total value of $305,600.00. Following the completion of the transaction, the vice president now directly owns 34,370 shares in the company, valued at $2,100,694.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Maureen J. Macinnis sold 45,100 shares of the stock in a transaction dated Thursday, August 25th. The shares were sold at an average price of $60.55, for a total value of $2,730,805.00. Following the completion of the transaction, the senior vice president now owns 36,730 shares of the company’s stock, valued at $2,224,001.50. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.
About Dentsply International
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dentsply International Inc. (NASDAQ:XRAY).
Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.